Outcome of relapsed/refractory AML patients with IDH1R132 mutations in real life before the era of IDH1 inhibitors. Issue 2 (28th January 2020) - Largeaud, Laetitia; Bertoli, Sarah; Bérard, Emilie; Dufrechou, Stéphanie; Prade, Naïs; Gadaud, Noémie; Tavitian, Suzanne; Bories, Pierre; Luquet, Isabelle; Sarry, Audrey; Mas, Véronique De; Huguet, Françoise; et al.